Alesco Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.73M Buy
6,829
+887
+15% +$207K 0.04% 84
2026
Q1
$1.45M Buy
5,942
+551
+10% +$128K 0.04% 86
2025
Q4
$1.12M Sell
5,391
-90
-2% -$17.8K 0.03% 97
2025
Q3
$1.02M Buy
5,481
+361
+7% +$61.8K 0.03% 99
2025
Q2
$782K Sell
5,120
-242
-5% -$37.2K 0.02% 103
2025
Q1
$889K Sell
5,362
-4
-0.1% -$626 0.03% 95
2024
Q4
$776K Buy
5,366
+98
+2% +$15.2K 0.02% 102
2024
Q3
$854K Hold
5,268
0.03% 96
2024
Q2
$770K Sell
5,268
-115
-2% -$17.1K 0.03% 101
2024
Q1
$852K Sell
5,383
-76
-1% -$12.1K 0.03% 96
2023
Q4
$856K Buy
5,459
+76
+1% +$11.7K 0.03% 94
2023
Q3
$838K Sell
5,383
-85
-2% -$14K 0.03% 92
2023
Q2
$905K Hold
5,468
0.03% 89
2023
Q1
$848K Sell
5,468
-115
-2% -$18.6K 0.03% 91
2022
Q4
$986K Sell
5,583
-310
-5% -$53.5K 0.04% 88
2022
Q3
$963K Buy
5,893
+345
+6% +$58.4K 0.04% 79
2022
Q2
$985K Hold
5,548
0.04% 79
2022
Q1
$983K Sell
5,548
-270
-5% -$45.9K 0.03% 80
2021
Q4
$995K Hold
5,818
0.03% 74
2021
Q3
$940K Sell
5,818
-120
-2% -$20.5K 0.03% 73
2021
Q2
$978K Hold
5,938
0.04% 74
2021
Q1
$976K Sell
5,938
-35
-0.6% -$5.66K 0.04% 73
2020
Q4
$940K Hold
5,973
0.04% 72
2020
Q3
$889K Buy
5,973
+205
+4% +$30.3K 0.04% 71
2020
Q2
$811K Sell
5,768
-265
-4% -$38.6K 0.04% 74
2020
Q1
$791K Sell
6,033
-6,713
-53% -$952K 0.05% 76
2019
Q4
$1.86M Buy
12,746
+5,524
+76% +$749K 0.1% 48
2019
Q3
$934K Sell
7,222
-295
-4% -$38.9K 0.05% 82
2019
Q2
$1.05M Buy
7,517
+1,740
+30% +$241K 0.06% 77
2019
Q1
$808K Sell
5,777
-151
-3% -$20.2K 0.04% 87
2018
Q4
$765K Sell
5,928
-306
-5% -$42.7K 0.05% 87
2018
Q3
$861K Buy
6,234
+240
+4% +$31.9K 0.05% 75
2018
Q2
$727K Hold
5,994
0.04% 77
2018
Q1
$768K Buy
5,994
+100
+2% +$13.5K 0.04% 76
2017
Q4
$823K Hold
5,894
0.05% 76
2017
Q3
$766K Buy
5,894
+159
+3% +$21.1K 0.05% 78
2017
Q2
$759K Sell
5,735
-475
-8% -$60.6K 0.05% 76
2017
Q1
$773K Buy
6,210
+696
+13% +$83.1K 0.05% 73
2016
Q4
$635K Hold
5,514
0.05% 76
2016
Q3
$651K Sell
5,514
-540
-9% -$65.5K 0.05% 73
2016
Q2
$734K Buy
6,054
+520
+9% +$59.1K 0.06% 67
2016
Q1
$599K Sell
5,534
-75
-1% -$7.76K 0.05% 72
2015
Q4
$576K Buy
5,609
+280
+5% +$28.2K 0.05% 72
2015
Q3
$497K Hold
5,329
0.05% 78
2015
Q2
$519K Sell
5,329
-150
-3% -$15K 0.05% 76
2015
Q1
$551K Buy
5,479
+300
+6% +$30.5K 0.05% 73
2014
Q4
$542K Hold
5,179
0.05% 72
2014
Q3
$552K Hold
5,179
0.05% 68
2014
Q2
$542K Hold
5,179
0.05% 70
2014
Q1
$509K Sell
5,179
-5,188
-50% -$481K 0.05% 68
2013
Q4
$950K Buy
10,367
+25
+0.2% +$2.3K 0.1% 56
2013
Q3
$897K Buy
10,342
+4,972
+93% +$446K 0.11% 49
2013
Q2
$461K Buy
+5,370
New +$456K 0.06% 58

Other funds holding JNJ

Alesco Advisors's JNJ Position: Q2 2026 in Review

Alesco Advisors increased its Johnson & Johnson (JNJ) stake by 15% in Q2 2026, buying an estimated $207K and bringing the position to 6,829 shares worth $1.73M. The position accounts for 0.04% of the portfolio, ranked #84.

Alesco Advisors first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.86M in Q4 2019. 3,174 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Alesco Advisors held 6,829 shares of Johnson & Johnson worth $1.73M as of Q2 2026.
  • Alesco Advisors bought 887 Johnson & Johnson shares in Q2 2026, an estimated $207K.
  • Johnson & Johnson made up 0.04% of Alesco Advisors's portfolio in Q2 2026, its #84 holding.
  • Alesco Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Alesco Advisors's Johnson & Johnson position peaked at $1.86M in Q4 2019.
  • 3,174 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Alesco Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.